Zurcher Kantonalbank (Zurich Cantonalbank) Omega Therapeutics, Inc. Transaction History

Zurcher Kantonalbank (Zurich Cantonalbank)

$32.8 Billion
Q3 2024

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2023 Jan 30, 2024	SELL	$1.35 - $3.21 $3,036 - $7,219	-2,249 Reduced 88.27%	299 $0
Q3 2023 Oct 25, 2023	SELL	$2.15 - $5.68 $1,806 - $4,771	-840 Reduced 24.79%	2,548 $5,000
Q2 2023 Aug 07, 2023	SELL	$5.6 - $9.66 $4,256 - $7,341	-760 Reduced 18.32%	3,388 $18,000
Q1 2023 May 08, 2023	BUY	$4.81 - $10.95 $19,951 - $45,420	4,148 New	4,148 $25,000

Others Institutions Holding OMGA

# of Institutions

Shares Held

43.4M

Call Options Held

25.8K

Put Options Held

Flagship Pioneering Inc. Cambridge, MA

29.2M
Shares

$23.1 Million
6.05% of portfolio
Harbourvest Partners LLC Boston, MA

3.51M
Shares

$2.77 Million
2.28% of portfolio
State Of Wisconsin Investment Board Madison, WI

1.86M
Shares

$1.47 Million
0.01% of portfolio
Siren, L.L.C. New York, NY

1.32M
Shares

$1.05 Million
0.08% of portfolio
Vanguard Group Inc Valley Forge, PA

1.11M
Shares

$880,637
0.0% of portfolio

View Full List

About Omega Therapeutics, Inc.

Ticker OMGA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 47,853,400
Market Cap $37.8M
Description
Omega Therapeutics, Inc. operates as a development-stage biopharmaceutical company. Its OMEGA Epigenomic Programming platform is designed to coopt nature's operating system by harnessing the power of epigenetics, the mechanism for gene control and cell differentiation. The company is developing omega epigenomic controller (OEC) candidates to up-...

More about OMGA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Zurcher Kantonalbank (Zurich Cantonalbank), based on Form 13F filings with the SEC.

News

Stay updated on Zurcher Kantonalbank (Zurich Cantonalbank) with notifications on news.

Account